Previous reports revealed that EZH2 acts as an oncogene in GB [18,19,20], promoting multiple glioma cellular processes, including cell cycle, cell invasion, and angiogenesis, which is thought to be responsible for cancer cells survival, drug resistance and tumor recurrence [19,21]. The gene discussed is EZH2; the disease is central nervous system cancer.